Antipsychotic use is associated with a blunted cortisol stress response: A study in euthymic bipolar disorder patients and their unaffected siblings

European Neuropsychopharmacology

Volumn 25, Issue 1, 2015, Pages 77-84

  Houtepen, L C ^a   Boks, M P M ^a   Kahn, R S ^a   Joels M ^a   Vinkers, C H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antipsychotic; Bipolar disorder; Medication; Siblings; Stress; TSST

Indexed keywords

AMYLASE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; HYDROCORTISONE; LITHIUM; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; EUTHYMIC BIPOLAR DISORDER; FEMALE; FOLLOW UP; GOOD CLINICAL PRACTICE; HUMAN; MALE; MENTAL STRESS; ONSET AGE; SALIVA LEVEL; SIBLING; STRESS; YOUNG MANIA RATING SCALE; ANALYSIS OF VARIANCE; BLOOD; COMPLICATION; DRUG EFFECTS; HEART RATE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; SALIVA; TIME; YOUNG ADULT;

ADULT; AGED; ALPHA-AMYLASES; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SALIVA; SIBLINGS; STRESS, PSYCHOLOGICAL; TIME FACTORS; YOUNG ADULT;

EID: 84920483708     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.10.005     Document Type: Article

References (53)

1. Bender R.E., Alloy L.B. Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories. Clin. Psychol. Rev. 2011, 31:383-398.
2. Bernstein D.P., Stein J.A., Newcomb M.D., Walker E., Pogge D., Ahluvalia T., Stokes J., Handelsman L., Medrano M., Desmond D., Zule W. Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl. 2003, 27:169-190.
3. Brenner K., Liu A., Laplante D.P., Lupien S., Pruessner J.C., Ciampi A., Joober R., King S. Cortisol response to a psychosocial stressor in schizophrenia: blunted, delayed, or normal?. Psychoneuroendocrinology 2009, 34:859-868.
4. Carpenter L.L., Carvalho J.P., Tyrka A.R., Wier L.M., Mello A.F., Mello M.F., Anderson G.M., Wilkinson C.W., Price L.H. Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biol. Psychiatry 2007, 62:1080-1087.
5. Cervantes P., Gelber S., Kin F.N., Nair V.N., Schwartz G. Circadian secretion of cortisol in bipolar disorder. J. Psychiatry Neurosci. 2001, 26:411-416.
6. Cohen H., Kaplan Z., Kotler M., Mittelman I., Osher Y., Bersudsky Y. Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord. 2003, 5:138-143.
7. Cohrs S., Roher C., Jordan W., Meier A., Huether G., Wuttke W., Ruther E., Rodenbeck A. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. Psychopharmacology (Berl) 2006, 185:11-18.
8. DeRijk R.H., de Kloet E.R. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur. J. Pharmacol. 2008, 583:303-311.
9. Ellenbogen M.A., Hodgins S., Walker C.D., Couture S., Adam S. Daytime cortisol and stress reactivity in the offspring of parents with bipolar disorder. Psychoneuroendocrinology 2006, 31:1164-1180.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient edition with Psychotic Screen (SCID-I/P W/PSY SCREEN) 2002, Biometrics Research, New York State Psychiatric Insitute, New York.
11. Fries E., Hellhammer D.H., Hellhammer J. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the trier social stress test by the benzodiazepine alprazolam. Psychoneuroendocrinology 2006, 31:1278-1288.
12. Heim C., Newport D.J., Heit S., Graham Y.P., Wilcox M., Bonsall R., Miller A.H., Nemeroff C.B. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000, 284:592-597.
13. Ising M., Holsboer F. Genetics of stress response and stress-related disorders. Dialogues Clin. Neurosci. 2006, 8:433-444.
14. Jansen L.M., Gispen-de Wied C.C., Gademan P.J., De Jonge R.C., van der Linden J.A., Kahn R.S. Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr. Res. 1998, 33:87-94.
15. Jansen L.M., Gispen-de Wied C.C., Kahn R.S. Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berl) 2000, 149:319-325.
16. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 1999, 61:154-162.
17. Kudielka B.M., Fischer J.E., Metzenthin P., Helfricht S., Preckel D., von K.R. No effect of 5-day treatment with acetylsalicylic acid (aspirin) or the beta-blocker propranolol (Inderal) on free cortisol responses to acute psychosocial stress: a randomized double-blind, placebo-controlled study. Neuropsychobiology 2007, 56:159-166.
18. Lake C.R., Pickar D., Ziegler M.G., Lipper S., Slater S., Murphy D.L. High plasma norepinephrine levels in patients with major affective disorder. Am. J. Psychiatry 1982, 139:1315-1318.
19. Lange C., Zschucke E., Ising M., Uhr M., Bermpohl F., Adli M. Evidence for a normal HPA axis response to psychosocial stress in patients remitted from depression. Psychoneuroendocrinology 2013, 38:2729-2736.
20. Lovallo W.R., Farag N.H., Sorocco K.H., Cohoon A.J., Vincent A.S. Lifetime adversity leads to blunted stress axis reactivity: studies from the Oklahoma family health patterns project. Biol. Psychiatry 2012, 71:344-349.
21. Maheu F.S., Joober R., Lupien S.J. Declarative memory after stress in humans: differential involvement of the beta-adrenergic and corticosteroid systems. J. Clin. Endocrinol. Metab. 2005, 90:1697-1704.
22. Makatsori A., Duncko R., Moncek F., Loder I., Katina S., Jezova D. Modulation of neuroendocrine response and non-verbal behavior during psychosocial stress in healthy volunteers by the glutamate release-inhibiting drug lamotrigine. Neuroendocrinology 2004, 79:34-42.
23. Miller G.A., Chapman J.P. Misunderstanding analysis of covariance. J. Abnorm. Psychol. 2001, 110:40-48.
24. Morris M.C., Rao U., Garber J. Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators. J. Affect. Disord. 2012, 143:223-230.
25. Nater U.M., Hoppmann C.A., Scott S.B. Diurnal profiles of salivary cortisol and alpha-amylase change across the adult lifespan: evidence from repeated daily life assessments. Psychoneuroendocrinology 2013.
26. Nater U.M., Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology 2009, 34:486-496.
27. Nater U.M., Rohleder N., Schlotz W., Ehlert U., Kirschbaum C. Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 2007, 32:392-401.
28. Ostiguy C.S., Ellenbogen M.A., Walker C.D., Walker E.F., Hodgins S. Sensitivity to stress among the offspring of parents with bipolar disorder: a study of daytime cortisol levels. Psychol. Med. 2011, 41:2447-2457.
29. Petrowski K., Wintermann G.B., Schaarschmidt M., Bornstein S.R., Kirschbaum C. Blunted salivary and plasma cortisol response in patients with panic disorder under psychosocial stress. Int. J. Psychophysiol. 2013, 88:35-39.
30. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry 1992, 149:999-1010.
31. Proudfoot J., Doran J., Manicavasagar V., Parker G. The precipitants of manic/hypomanic episodes in the context of bipolar disorder: a review. J. Affect. Disord. 2011, 133:381-387.
32. Ritsner M., Gibel A., Maayan R., Ratner Y., Ram E., Biadsy H., Modai I., Weizman A. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia. Neuropsychopharmacology 2005, 30:1913-1922.
33. Roelofs K., van Peer J., Berretty E., Jong P., Spinhoven P., Elzinga B.M. Hypothalamus-pituitary-adrenal axis hyperresponsiveness is associated with increased social avoidance behavior in social phobia. Biol. Psychiatry 2009, 65:336-343.
34. Rohleder N., Nater U.M., Wolf J.M., Ehlert U., Kirschbaum C. Psychosocial stress-induced activation of salivary alpha-amylase: an indicator of sympathetic activity?. Ann. NY Acad. Sci. 2004, 1032:258-263.
35. Rush A.J., Giles D.E., Schlesser M.A., Orsulak P.J., Parker C.R., Weissenburger J.E., Crowley G.T., Khatami M., Vasavada N. The dexamethasone suppression test in patients with mood disorders. J. Clin. Psychiatry 1996, 57:470-484.
36. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol. Med. 1996, 26:477-486.
37. Rybakowski J.K., Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J. Psychiatr. Res. 1999, 33:363-370.
38. Schmider J., Lammers C.H., Gotthardt U., Dettling M., Holsboer F., Heuser I.J. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol. Psychiatry 1995, 38:797-802.
39. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):S22-S33.
40. Spijker A.T., Giltay E.J., van Rossum E.F., Manenschijn L., DeRijk R.H., Haffmans J., Zitman F.G., Hoencamp E. Glucocorticoid and mineralocorticoid receptor polymorphisms and clinical characteristics in bipolar disorder patients. Psychoneuroendocrinology 2011, 36:1460-1469.
41. Tohen M., Jacobs T.G., Grundy S.L., McElroy S.L., Banov M.C., Janicak P.G., Sanger T., Risser R., Zhang F., Toma V., Francis J., Tollefson G.D., Breier A. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW study group. Arch. Gen. Psychiatry 2000, 57:841-849.
42. van Leeuwen N., Bellingrath S., de Kloet E.R., Zitman F.G., DeRijk R.H., Kudielka B.M., Wust S. Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response. Psychoneuroendocrinology 2011, 36:699-709.
43. van Stegeren A., Rohleder N., Everaerd W., Wolf O.T. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrinology 2006, 31:137-141.
44. van Venrooij J.A., Fluitman S.B., Lijmer J.G., Kavelaars A., Heijnen C.J., Westenberg H.G., Kahn R.S., Gispen-de Wied C.C. Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophr. Bull. 2012, 38:272-279.
45. van Winkel R., van Nierop M., Myin-Germeys I., van Os J. Childhood trauma as a cause of psychosis: linking genes, psychology, and biology. Can. J. Psychiatry 2013, 58:44-51.
46. Vinkers C.H., Joels M., Milaneschi Y., Kahn R.S., Penninx B.W., Boks M.P. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depress. Anxiety. 2014, 31:737-745.
47. Vinkers C.H., Zorn J.V., Cornelisse S., Koot S., Houtepen L.C., Olivier B., Verster J.C., Kahn R.S., Boks M.P., Kalenscher T., Joels M. Time-dependent changes in altruistic punishment following stress. Psychoneuroendocrinology 2013, 38:1467-1475.
48. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol. 2008, 4:189-216.
49. Watson S., Gallagher P., Ritchie J.C., Ferrier I.N., Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry 2004, 184:496-502.
50. Wieck A., Grassi-Oliveira R., Do Prado C.H., Rizzo L.B., de Oliveira A.S., Kommers-Molina J., Viola T.W., Teixeira A.L., Bauer M.E. Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder. Brain Behav. Immun. 2013, 34:47-55.
51. Wolfe J., Kimerling R., Brown P.J. Psychometric review of the life stressor checklist-revised. Instrumentation in Stress, Trauma, and Adaptation 1996, 141-151. Sidran Press, Lutherville, MD, USA.
52. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64:663-667.
53. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.